Atavistik Bio

Atavistik Bio is a preclinical-stage biotechnology company dedicated to identifying allosteric small molecule-protein interactions, with the potential to discover and develop first-in-class drug compounds in the fields of oncology and metabolic diseases. Atavistik Bio was founded by distinguished scientists recognized as leading authorities in cell biology, cancer cell biology, and cellular metabolism. Backed by an experienced management team and advisory board, along with a strong consortium of investors, Atavistik is well-positioned to deliver transformative science that will ultimately improve patient care.